Proteome Sciences, Buck Institute Partner on Test for Breast Cancer Treatment Response

The partners will co-develop mass spectrometry-based tests to predict patient response to therapies such as tamoxifen.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.